Archive:
In Germany, around 10,000 strokes per year could be prevented. This is shown by the stroke care report presented for the first time by DAK-Gesundheit, which highlights the entire care chain for ischemic cerebral infarction - from primary prevention through treatment to rehabilitation. In this report, the first in a series of reports intended to look at current care in a number of focus indications in Germany from a new perspective, the IGES Institute commissioned to do so is based on the methodological model of the so-called “Generalized Cost-Effectiveness Analysis”. which was developed by the World Health Organization (WHO) as part of the “WHO-CHOICE” research program.
04.06.2014
As an information service provider for the Federal Ministry of Health, the German Institute for Medical Documentation and Information (DIMDI) is responsible, among other things, for the publication (and in some cases further development) of official classifications and medical terminologies. It is responsible for parts of the ministry's IT platform, manages cross-agency IT projects and operates various extensive information systems (e.g. on drugs, medical devices, health technology assessments) and supplementary databases; This also applies to the supply data information system (data transparency), which began pilot operation in February 2014. DIMDI director Dr. Dietrich Kaiser and Dr. Jochen Dreß, who is largely responsible for the project on the supply data information system, answered questions from “Monitor Supply Research” about the current approach to making the so-called DaTraV data available.
04.06.2014
In 1999 Dr. Klaus Cichutek, biochemist and adjunct professor of biochemistry at the Johann Wolfgang Goethe University Frankfurt, the role of permanent representative of the president of the Paul Ehrlich Institute (PEI), from October 31, 2001 to November 30, 2009 he was vice president, He has been President of the Paul Ehrlich Institute since December 1, 2009. Prof. Cichutek gave a lecture at the AMNOG conference that received extraordinary applause.
04.06.2014
The motto “Palliative - Care - Research” of the joint 10th Congress of the German Society for Palliative Medicine and the 13th German Congress for Health Care Research was chosen carefully and with an eye to the future. This was made clear by Prof. Dr. Edmund AM Neugebauer, Chairman of the German Network for Health Care Research (DNVF) and Prof. Dr. Friedemann Nauck, President of the German Society for Palliative Medicine, in a joint “introductory game” which – including exchanging jerseys – was entirely in the spirit and language of the Football World Cup, which was still ongoing at the time. Nauck wore jersey number 20 (for 20 years of DGP) and Neugebauer wore jersey number 8 (for 8 years of DNVF).
04.06.2014
The discussion about the transparency of clinical study reports (CSR) continues. The European Medicines Agency (EMA) has an important role to play here, as it is – actually – committed to “complete transparency” when it comes to access to study data. In May of this year, however, the EMA caused great dismay among the professional public with an interim version of its transparency policy. CSR data should therefore only be viewed by third parties on the screen, but not saved, copied or edited. After scientists, and not least the European Ombudsman Emily O'Reillly, criticized the EMA's departure from its original transparency course, the authority revised this restriction. “MVF” asked Prof. Antes, director of the German Cochrane Center, for his opinion on the EMA’s zigzag course.
04.06.2014
Biopharmaceuticals have become an integral part of the drug therapy of many diseases. With increasing sales in this market, biopharmaceuticals are responsible for a significant portion of statutory health insurance drug expenditure. For this reason, the timely market launch of biosimilars after the patent expiry of the original preparations is of crucial importance. Biosimilar manufacturers and various health insurance companies have great interest in steadily and comprehensively increasing the biosimilar market share. The analysis by INSIGHT Health shows that care in Germany is not uniform.
04.06.2014
The 10th Congress of the German Society for Palliative Medicine and the 13th German Congress for Health Services Research took place together in Düsseldorf in June under the motto “Palliative - Care - Research”, also to show that palliative medicine and hospice work are not just based on the idea of evidence , but also want to devote more attention to health services research. 300 abstracts from palliative medicine and hospice work and a further 150 from health services research proved the initiators - the German Society for Palliative Medicine (DPG) and the German Network for Health Care Research (DNVF) - right. “Monitor Healthcare Research” spoke to one of the three congress presidents, Prof. Dr. Raymond Voltz, director of the Center for Palliative Medicine at the University Hospital of Cologne.
04.06.2014
Dr. Benjamin Mayer, Prof. Dr. Rainer Muche (Institute for Epidemiology and Medical Biometry at the University of Ulm) on the article C. Haupt, C. Günster: “Statistical risk models: Possible applications for optimizing patient care” in “Monitor Healthcare Research” 01/2013, pages 36-39
23.07.2013
The next National Care Guideline (NVL) for the treatment of type 2 diabetes has just been published. It is jointly supported by all relevant professional societies, but it contains two very different assessments of self-monitoring as well as two treatment pathways, at least from the second stage of pharmacological monotherapy onwards.
23.07.2013
Regional differences in outpatient drug care are currently a focus of healthcare research. In this article, we take a more detailed look at the supply of antidepressants in Bavaria at the level of the eight regional associations of statutory health insurance physicians (KV districts). It should be noted from the outset that the KV districts in Bavaria differ significantly.